The journey is often as crucial as the destination. While entrepreneurs pour their energy into building and growing their ventures, it's equally important to plan for the inevitable endpoint\u200a-\u200athe exit. Exit strategy planning is a fundamental aspect of business strategy that extends far be

4 views • 3 slides

Delve into the origins and meaning of strategy, tracing it back to its Greek roots and understanding its role as a guiding roadmap for organizations. Experts like Alfred P. Chandler and Kenichi Ohmae offer insights into the definition and features of strategy, emphasizing its importance in achieving

7 views • 37 slides

This presentation delves into flood risk assessment using HEC-FDA software, covering topics such as defining flood risk, components of uncertainty, consequences of flood risk, and methods to assess flood risk including hydrology, hydraulics, geotechnical, and economics. It explores the intersection

6 views • 39 slides

Leveraging Technical Advisory Services for IT Strategy & Digital Transformation\n\nIn today's rapidly evolving technological landscape, businesses face the constant challenge of staying ahead of the curve. The convergence of IT strategy, digital transformation, cloud solutions, and cybersecurity has

4 views • 2 slides

The FDA announced its Final Rule on laboratory-developed tests (LDTs), considering them as regulated medical devices. The phased-out policy will gradually enforce compliance with premarket review, quality system regulation, and other requirements over several stages. Additionally, a limited enforcem

2 views • 6 slides

The FDA presents insights on the development and use of Epidemiological Cut-off Values (ECVs) to distinguish wild-type populations from those with acquired resistance mechanisms. ECVs are crucial for determining antimicrobial susceptibility and guiding treatment decisions. The process involves analy

0 views • 13 slides

Explore the experience of participating in the FDA's CID Pilot Meeting, focusing on designing a Phase 3 study for DLBCL with an external control arm for secondary overall survival. Discover key considerations for future studies with external controls to address high unmet medical needs in DLBCL pati

0 views • 13 slides

The Food and Drug Administration (FDA) plays a crucial role in regulating research, manufacturing, marketing, and distribution of medical devices. Medical devices are classified based on risk and intended use, with three main categories determining regulatory pathways. The classification system help

2 views • 27 slides

The FDA conducts audits to ensure compliance with regulations in research settings. The process involves site notification, preparation, visit, and final determinations. Site preparation includes alerting staff, reserving rooms, ensuring access to necessary equipment, and preparing relevant document

0 views • 17 slides

Drug regulation involves controlling drug use through international agreement authorities like the FDA, EMA, and PMDA. The FDA plays a crucial role in drug evaluation and research, biologic evaluation, devices, and food safety. There are various types of applications for drug approval, along with a

0 views • 28 slides

The New Drug Application (NDA) submission process to the FDA involves extensive documentation of non-clinical, clinical, and drug chemistry data to support the product's labeling. Key decisions during the FDA review include evaluating the drug's safety, effectiveness, labeling, manufacturing methods

0 views • 19 slides

Explore the evolution of ethical protections in research involving human subjects, from key historical events to current regulations governing VA research. Understand the responsibilities of investigators and entities in the approval process, along with pathways for accessing drugs via FDA's Expande

0 views • 25 slides

An Investigational New Drug Application (INDA) is a crucial submission to the FDA for permission to conduct clinical studies on new drug products. It plays a pivotal role in assessing the safety and efficacy of new drugs before they can be marketed and distributed for human use. This article covers

0 views • 30 slides

Hana Lee, Ph.D., presents a webinar on the Targeted Learning Framework for Causal Effect Estimation using Real World Data (TMLE). The project aims to help the FDA develop a structured approach to incorporating real-world data into regulatory decision-making. TMLE offers a systematic roadmap aligned

0 views • 27 slides

The FDA approval process for new medical devices involves rigorous evaluations to ensure safety and effectiveness. Conflicting criticisms of the FDA focus on the balance between tightening or loosening regulations without compromising public health. The agency's mission emphasizes protection and adv

0 views • 19 slides

IAS helps organizations to register their products in US FDA. It is always a tedious process to collect and file the application as the US-FDA has got stringent rules. We are having experience in US-FDA registration thus we put forward our Services t

3 views • 2 slides

This training addresses the ethical principles and regulations governing VA research involving human subjects, focusing on conducting FDA-regulated Expanded Access Program activities for Monkeypox treatment. It covers historical events shaping research practices, key responsibilities of investigator

0 views • 25 slides

Janice Hitchcock, Ph.D., discussed the new FDA guidance on early Alzheimer's disease in a webinar. The guidance highlights key sections such as introduction, background, and diagnostic criteria. It emphasizes the importance of early intervention, appropriate outcome measures, and diagnostic criteria

0 views • 13 slides

COVID-19 vaccines authorized in the US have undergone rigorous safety assessments with large trial participant numbers. The FDA and CDC actively monitor for any safety signals. The vaccines are proven safe and effective, developed quickly due to global collaboration and resources. Trust in the vacci

0 views • 12 slides

This information provides insights into the organizational structure and functions of the FDA Office of Regulatory Affairs (ORA) and the Office of Regulatory Science (ORS). It includes organizational charts, details about ORA laboratory locations, and the local structure of an ORA laboratory. Additi

1 views • 31 slides

U.S. FDA developed an initiative to educate the public on agricultural biotechnology, addressing misinformation and promoting science-based information. The initiative involves research, stakeholder consultations, and the release of materials in multiple languages to increase consumer understanding

0 views • 12 slides

Explore the history of FDA involvement in clinical software regulation, the role of CCHIT, changes in EHR certification due to the HITECH Act, and recent efforts to enhance EHR safety. Learn about certification processes, FDA's role in regulation, challenges faced, and the importance of human interv

0 views • 32 slides

FDA showcases illustrative examples of how Real-World Evidence (RWE) has been utilized in regulatory decisions, highlighting its value across different submission types, data sources, and purposes from FY12-FY19. The FDA report features cases like a modified hemodialysis catheter end cap, tumor prof

0 views • 14 slides

Strategy and tactics play crucial roles in educational design, guiding the use of tools and techniques for effective learning outcomes. Sun Tzu's insight on victory being rooted in unseen strategy resonates in the realm of instructional design. The distinction between strategy (the overarching plan)

1 views • 9 slides

E-cigarettes, unregulated and not FDA-approved, pose health risks with potential carcinogens and toxic chemicals. Lack of oversight allows for manufacturers to sell products with varying safety standards. FDA testing has revealed concerning findings, yet regulations are limited in addressing key iss

0 views • 40 slides

Explore the various substance abuse treatment approaches, including psychological and pharmacological interventions, along with FDA-approved medications like disulfiram, naltrexone, and buprenorphine. Learn about the challenges in substance abuse treatment and the psychology of substance users. Disc

0 views • 13 slides

Access resources and information to successfully import FDA regulated products using ACE. The Office of Enforcement and Import Operations and Office of Information Systems Management at the US Food and Drug Administration provide guidance in this August 2017 publication.

0 views • 157 slides

Gain insights from Joyce Nancarrow Tull, an experienced professional, on navigating FDA inspections successfully. Learn about legal authority, inspection procedures, key strategies, and more. Be proactive, seek expert advice, and build knowledge to enhance your readiness for FDA audits.

0 views • 31 slides

The Food and Drug Administration (FDA) in the USA is a critical agency within the Department of Health and Human Services responsible for regulating the safety of various products such as foods, drugs, medical devices, and cosmetics. The FDA has distinct organizational units like the Office of the C

0 views • 49 slides

Dental materials play a crucial role in various dental procedures such as implants, onlays, crowns, and bridges. Different materials like titanium and ceramics are utilized, with standards set by organizations like the ADA, ISO, and FDA. Safety and quality assurance are vital for restorative dental

0 views • 10 slides

FDA regulations in clinical research cover the protection of human subjects, IND/IDE requirements, risk determinations, application processes, and what falls under FDA regulation. It distinguishes between FDA-regulated activities and those not regulated, such as medical record reviews. The scope inc

0 views • 31 slides

This content discusses different types of strategy maps including the Balanced Scorecard, Classic Kaplan/Norton Strategy Map, Generic Example Strategy Map, and Basic Strategy Map Background. Each map highlights different perspectives such as financial, customer, internal, and learning & growth, alon

0 views • 22 slides

Dr. Shukri Olow and David Gistarb conducted an open house information session on the Youth Development Strategy. The session covered topics such as Best Starts for Kids, unique aspects of the strategy, RFP overview, and funding specifics. The strategy focuses on promoting equity, social justice, and

0 views • 16 slides

Michael Cohen-Wolkowiez, MD PhD, a Pediatric Trials Network Professor at Duke University, conducted a bioanalysis validation case study involving Meropenem in infants funded by NIH. The study focused on PK and safety data for FDA registration consideration. High-level results showed significant diff

0 views • 6 slides

Development of Malawi's eHealth Strategy was completed in December 2014, following the WHO/ITU eHealth Strategy Development Toolkit approval in December 2015. The strategy had a two-year implementation period that expired in 2016. Currently, the Health Sector Strategic Plan is in progress, with the

0 views • 13 slides

Background of off-label use and prohibition, First Amendment challenges to FDA authority, next steps for industry and FDA in responding to the new legal landscape. FD&C Act prohibits misleading labeling, FDA's regulatory authority on drug and device promotions, FDA's view on off-label promotion proh

0 views • 19 slides

Explore the world of biosimilars, the complexities of comparing generic and brand drugs, FDA regulations, and the first FDA-approved biosimilar. Learn about biological products, the Biologics Price Competition and Innovation Act, and the challenges in defining potency, purity, and stability in biolo

0 views • 26 slides

Effective management of urinary tract infections (UTIs) during pregnancy involves promoting urinary health, emphasizing safety of antimicrobial treatment, and understanding FDA categories for medication use. Recommendations include fluid intake, perineal hygiene, and maintaining bladder health. Safe

0 views • 13 slides

Cocaine use is a significant public health concern in the US, affecting many communities. A preliminary study by Johns Hopkins School of Medicine suggests that abstaining from cocaine and reducing its use may lead to decreased endothelial damage in African Americans. FDA has not approved medications

0 views • 32 slides

EDRN investigators can approach the FDA for pre-submission without an industry partner for proposed early detection study designs. The process involves validation, verification, and discovery stages in the biomarker pipeline, utilizing various technologies and biospecimen sets. An example from the o

0 views • 18 slides